Browse 2637 Federal Food and Nutrition Grants below, sorted by the deadline to apply.
The United States Government agency or department offering the grant is also listed.
Select a specific Food and Nutrition grant to read the full description of the opportunity.
The full description contains the grant type, total award amount, eligible applicants, important dates, and official contact details.
If you wish to search for a specific keyword or view grants sorted by governmental agency, use the links on the menu bar.
| Close Date | Grant Title | Agency |
| June 18th, 2024 |
FY 2024 SNAP Process and Technology Improvement Grant |
Food and Nutrition Service |
| April 26th, 2025 |
Private Sector Collaboration Pathway (PSCP) Jordan Addendum |
Jordan USAID Amman |
| June 17th, 2024 |
Convener and Organizer of Activities and Engagements Related to Processes, Surveillance, and Policy Development of Medical Products for Ongoing Public Health Activities, U01 Clinical Trial Not Allowed |
Food and Drug Administration |
| May 6th, 2027 |
Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clinical Trial Not Allowed) |
National Institutes of Health |
| May 6th, 2027 |
Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clinical Trial Required) |
National Institutes of Health |
| April 17th, 2024 |
Fiscal Year 2024 Emergency Food and Shelter National Board Program |
Department of Homeland Security FEMA |
| June 15th, 2025 |
Kidney Technology Development Research Education Program (R25 - Independent Clinical Trial Not Allowed) |
National Institutes of Health |
| August 13th, 2024 |
Rare Diseases Clinical Research Consortia (RDCRC) for the Rare Diseases Clinical Research Network (RDCRN) (U54 Clinical Trial Optional) |
National Institutes of Health |
| July 17th, 2024 |
Adaptation of Diabetes Control Technologies for Older Adults with T1D (R01 Clinical Trial Optional) |
National Institutes of Health |
| July 9th, 2024 |
Discovery of Early Type 1 Diabetes Disease Processes in the Human Pancreas [HIRN Consortium on Beta Cell Death and Survival (CBDS)] (U01 Clinical Trial Not Allowed) |
National Institutes of Health |
| June 18th, 2024 |
Diabetes Research Centers (P30 Clinical Trial Optional) |
National Institutes of Health |
| January 15th, 2027 |
HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed) |
National Institutes of Health |
| April 11th, 2024 |
2024-draft-ifrp-transport-rfa-draft |
Agency for International Development |
| January 7th, 2025 |
Pilot Studies of Biological, Behavioral and Social Mechanisms Contributing to HIV Pathogenesis Within the Mission of NIDDK (R21 Clinical Trial Not Allowed) |
National Institutes of Health |
| May 20th, 2024 |
Development and Maintenance of the Animal Food Regulatory Program Standards (U19) Clinical Trial Not Allowed |
Food and Drug Administration |
| January 7th, 2027 |
Support for Research Excellence First Independent Research (SuRE-First) Award (R16 - Clinical Trial Not Allowed) |
National Institutes of Health |
| January 7th, 2027 |
Support for Research Excellence (SuRE) Award (R16 Clinical Trial Not Allowed) |
National Institutes of Health |
| May 20th, 2024 |
Use of Digital Health Technologies in Clinical Investigations to Support Drug and Biological Product Development (U01) Clinical Trials Optional |
Food and Drug Administration |
| December 9th, 2026 |
Innovations for Healthy Living - Improving Minority Health and Eliminating Health Disparities (R43/R44 - Clinical Trial Optional) |
National Institutes of Health |
| April 29th, 2024 |
PDS Annual Program Statement 2024 |
US Mission to France |
|
| January 7th, 2027 |
NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed) |
National Institutes of Health |
| May 10th, 2024 |
Cooperative Agreement to Support the World Trade Organization's (WTO) Standards and Trade Development Facility (STDF) (U01) Clinical Trials Not Allowed |
Food and Drug Administration |
| May 6th, 2024 |
Alliance to Support the Activities of the Integrated Food Safety System (IFSS), including the Grade A Milk Safety and National Shellfish Sanitation Programs (U01) Clinical Trials Not Allowed |
Food and Drug Administration |
| January 7th, 2026 |
Elucidating Mechanisms Associated with HIV Related Co-Morbidities in Populations Experiencing Health Disparities (R01 - Clinical Trials Not Allowed) |
National Institutes of Health |
| January 7th, 2025 |
Priority HIV/AIDS Research within the Mission of NIDDK (R01 Clinical Trial Optional) |
National Institutes of Health |
| July 30th, 2024 |
Impact of Comorbidities and Co-Infections on HIV Reservoirs (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
| May 13th, 2024 |
Cooperative Agreement for Long Term Data Collection on Antimicrobial Use in Animals (U01) Clinical Trial Not Allowed |
Food and Drug Administration |
| May 13th, 2025 |
Drug Development Tools Research Grants (U01) Clinical Trials Optional |
Food and Drug Administration |
| April 1st, 2024 |
Advancing Conformance with the Voluntary National Retail Food Regulatory Program Standards (VNRFRPS) by State, Local, Tribal, and Territorial (SLTT) Retail Food Regulatory Agencies (U19) Clinical Trials Not Allowed |
Food and Drug Administration |
| April 1st, 2024 |
Development and Maintenance of Human and Animal Food Rapid Response Teams (U2F) Clinical Trials Not Allowed |
Food and Drug Administration |
| April 1st, 2024 |
Flexible Funding Model-Infrastructure Development and Maintenance for State Manufactured Food Regulatory Programs (U19) Clinical Trials Not Allowed |
Food and Drug Administration |
| April 5th, 2024 |
Novel Approaches to Support Therapeutic Development in Ultra-Rare Cancers (U01) Clinical Trial Optional |
Food and Drug Administration |
| June 27th, 2024 |
Continuous Ketone Monitoring for the Safe Use of Sodium-glucose Cotransporter-2 Inhibitors in Type 1 Diabetes (R01 Clinical trial Required) |
National Institutes of Health |
| March 18th, 2024 |
Supporting the Use of Traditional Indigenous Foods in the Child Nutrition Programs |
Food and Nutrition Service |
| March 31st, 2024 |
Synthesis and Biological Activity Assessment of Different Diastereomers in siRNA Drug LEQVIO (Inclisiran) (U01) Clinical Trial Not Allowed |
Food and Drug Administration |
| March 31st, 2024 |
Identification of Drug-related and Formulation-Related Factors that Result in Alcohol Dose Dumping of Modified Release Oral Drug Products (U01) Clinical Trial Not Allowed |
Food and Drug Administration |
| March 31st, 2024 |
Improving Predictability of Food-Drug and Drug-Drug Interaction Risks by Utilizing In Vitro Simulated Gastrointestinal Dissolution Model for High-Risk Oral Drug Products (U01) Clinical Trial Optional |
Food and Drug Administration |
| March 31st, 2024 |
Evaluating the Cutaneous Pharmacokinetics of Topical Drug Products Using Pharmacokinetic Tomography (U01 Clinical Trial Required) |
Food and Drug Administration |
| March 31st, 2024 |
Utilizing Real-World Data and Algorithmic Analyses to Assess Post-Market Clinical Outcomes in Patients Switching Amongst Therapeutically Equivalent Complex Generic Drug Products and Reference Listed Drugs (U01) Clinical |
Food and Drug Administration |
| March 31st, 2024 |
Developing PBPK Model-Based Mechanistic IVIVCs for Long Acting Injectable Suspensions and Implants (U01) Clinical Trial Optional |
Food and Drug Administration |
